A detailed history of Exodus Point Capital Management, LP transactions in Ocugen, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 37,981 shares of OCGN stock, worth $34,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,981
Holding current value
$34,562
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.98 - $1.95 $37,221 - $74,062
37,981 New
37,981 $38,000
Q1 2023

May 11, 2023

BUY
$0.82 - $1.33 $171,742 - $278,557
209,442 New
209,442 $179,000
Q3 2022

Nov 10, 2022

BUY
$1.75 - $3.1 $79,661 - $141,115
45,521 New
45,521 $81,000
Q1 2022

May 13, 2022

SELL
$2.34 - $4.72 $52,095 - $105,081
-22,263 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$4.38 - $15.67 $97,511 - $348,861
22,263 New
22,263 $101,000
Q1 2020

May 15, 2020

SELL
$0.26 - $0.73 $5,798 - $16,279
-22,300 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.27 - $2.19 $6,021 - $48,837
22,300 New
22,300 $12,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $197M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.